Andrew I Su Selected Research

Metolazone (Diulo)

4/2022	Design and application of a knowledge network for automatic prioritization of drug mechanisms.
1/2022	Design and application of a knowledge network for automatic prioritization of drug mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew I Su Research Topics

Disease

7	Neoplasms (Cancer) 04/2022 - 10/2002
3	Osteoporosis 04/2022 - 06/2009
3	Osteoarthritis 10/2020 - 01/2016
3	Inflammation (Inflammations) 01/2018 - 04/2008
2	Asthma (Bronchial Asthma) 04/2022 - 01/2022
2	Infections 01/2009 - 11/2002
1	Ulcerative Colitis 01/2022
1	Carcinogenesis 11/2020
1	COVID-19 10/2020
1	Cryptosporidiosis 10/2018
1	Genomic Instability 05/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Colitis 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	hereditary Xerocytosis 01/2018
1	Dysbiosis 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Breast Neoplasms (Breast Cancer) 05/2015
1	Wounds and Injuries (Trauma) 05/2015
1	Hyperalgesia 05/2015
1	Dental Caries (Decay, Dental) 01/2014
1	Dental Plaque 01/2014
1	Adenocarcinoma 01/2011
1	Viremia 01/2009
1	Hepatocellular Carcinoma (Hepatoma) 01/2009
1	Gallstones (Gallstone) 12/2004
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 10/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2002
1	Carcinoma (Carcinomatosis) 10/2002
1	Colonic Neoplasms (Colon Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 04/2022 - 05/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	Transcription Factors (Transcription Factor)IBA 10/2020 - 10/2002
4	Biological ProductsIBA 01/2018 - 07/2002
3	RNA (Ribonucleic Acid)IBA 06/2015 - 01/2014
2	Imatinib Mesylate (Gleevec)FDA Link 04/2022 - 01/2022
2	Metolazone (Diulo)FDA LinkGeneric 04/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2009 - 11/2002
2	Messenger RNA (mRNA)IBA 01/2009 - 07/2002
1	Serine (L-Serine)FDA Link 01/2022
1	EndopeptidasesIBA 01/2022
1	Transfer RNA (tRNA)IBA 11/2020
1	Ligases (Synthetase)IBA 11/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2020
1	1- palmityl- 2- (4- carboxybutyl)- sn- glycero- 3- phosphocholineIBA 10/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2018
1	Proteoglycans (Proteoglycan)IBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	ProteomeIBA 01/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Nicotine FDA Link 05/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2015
1	SugarsIBA 01/2014
1	AcidsIBA 01/2014
1	CateninsIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 06/2009
1	Mevalonic Acid (Mevalonate)IBA 01/2009
1	25-hydroxycholesterolIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2008
1	HDL LipoproteinsIBA 12/2004
1	Casein Kinase 1 epsilonIBA 10/2002
1	Lymphoid Enhancer-Binding Factor 1IBA 07/2002
1	Nylons (Nylon)IBA 07/2002

Therapy/Procedure

2	Precision Medicine 05/2015 - 08/2014
1	Biological Therapy 11/2020
1	Therapeutics 10/2020
1	Analgesia 05/2015